Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heart failure as a metabolic problem.

S D Anker1, M Rauchhaus

  • 1Department of Cardiac Medicine, National Heart and Lung Institute, London, UK. s.anker@ic.ac.uk

European Journal of Heart Failure
|August 11, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The association between iron deficiency and outcomes: a secondary analysis of the intravenous iron therapy to treat iron deficiency anaemia in patients undergoing major abdominal surgery (PREVENTT) trial.

Anaesthesia·2022
Same author

International Exercise Recommendations in Older Adults (ICFSR): Expert Consensus Guidelines.

The journal of nutrition, health & aging·2021
Same author

Tumour biomarkers: association with heart failure outcomes.

Journal of internal medicine·2020
Same author

Novel endotypes in heart failure: effects on guideline-directed medical therapy.

European heart journal·2018
Same author

International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management.

The journal of nutrition, health & aging·2018
Same author

[Iron deficiency : Recognition and treatment].

Der Internist·2017
Same journal

A high proportion of children with severe cardiomyopathies show both myocarditis and genetic predispositions.

European journal of heart failure·2026
Same journal

Correction to: Association of patient-centred remote monitoring with clinical outcomes in patients with prior hospitalization: the TELESAT PRIOR-HF study.

European journal of heart failure·2026
Same journal

Prevention of Heart Failure in Women: An Expert Consensus Statement on Sex-Specific Risk Factors.

European journal of heart failure·2026
Same journal

"Reply to Murthy et al. regarding AI-derived LVOT-VTI for monitoring disease progression in transthyretin cardiac amyloidosis".

European journal of heart failure·2026
Same journal

High serum transthyretin concentrations identify a low likelihood of advanced myocardial amyloid burden in suspected ATTR cardiomyopathy.

European journal of heart failure·2026
Same journal

Consistent Efficacy of Vutrisiran Across Sexes in Transthyretin Cardiac Amyloidosis: Evidence from the HELIOS-B Trial.

European journal of heart failure·2026
See all related articles

Chronic heart failure (CHF) is a complex metabolic syndrome involving hemodynamic, neurohormonal, and immunological factors. Understanding these metabolic changes is crucial for developing new treatments to improve patient prognosis.

Area of Science:

  • Cardiology
  • Endocrinology
  • Immunology

Background:

  • Chronic heart failure (CHF) is a growing public health concern.
  • CHF involves complex interactions between hemodynamic, neurohormonal, immunological, and endocrine systems.
  • Initially adaptive, these secondary mechanisms can worsen CHF progression.

Purpose of the Study:

  • To review the metabolic features of CHF patients.
  • To discuss the immunological and neuroendocrine aspects contributing to CHF pathogenesis.
  • To highlight CHF as a multifactorial metabolic syndrome.

Main Methods:

  • Literature review focusing on metabolic, immunological, and neuroendocrine pathways in CHF.
  • Analysis of current understanding of CHF pathogenesis.

Related Experiment Videos

  • Synthesis of evidence linking metabolic dysfunction to CHF outcomes.

    • Main Results:

    • CHF is characterized by significant metabolic disturbances.
    • Immunological and neuroendocrine dysregulation plays a key role in CHF.
    • Advanced CHF can manifest as cardiac cachexia, indicating a poor prognosis.

    Conclusions:

    • CHF is a multifactorial metabolic syndrome.
    • Therapeutic strategies should target the metabolic status of CHF patients.
    • Interdisciplinary collaboration among cardiologists, endocrinologists, and immunologists is essential for improved CHF management.